Newsroom

RTHMS today announced the launch of a new category of consumer technology: behavioral compatibility, a system designed to connect people based not on who they say they are, but on how they actually live.

While traditional dating apps rely on static profiles, photos, and self described traits, RTHMS operates on a fundamentally different premise: real compatibility is revealed through real world behavior over time. Daily routines, movement, wellness habits, food choices, travel patterns, and lifestyle rhythms become meaningful signals for connection.

Rather than freezing compatibility at a single moment, RTHMS reflects how people’s lives actually unfold.

At the core of the platform is a proprietary translation layer that converts real world behavior into Habit Tags: dynamic, high level compatibility signals that reflect how someone lives without exposing raw data or personal details. These signals update continuously, allowing compatibility to evolve naturally as behavior changes.

By translating lived behavior into Habit Tags, RTHMS makes compatibility observable rather than speculative, reducing misalignment and improving the quality of human connection.

RTHMS launches with dating as its primary use case, where misalignment is most visible and costly. At the same time, the platform is built for non daters from day one, offering compatibility insight and self alignment even for users who are not actively seeking romantic relationships. Dating is the entry point, not the ceiling.

Privacy and security are foundational to RTHMS’s architecture. The platform operates as a filtering layer, translating behavioral inputs into Habit Tags without storing raw personal data. Underlying source data is anonymized, abstracted, and discarded after processing. RTHMS does not sell personal data, does not create advertising profiles, and does not rely on invasive data retention models.

RTHMS was founded by Jason Winkler and is supported by early stage backers and advisors with experience across consumer technology, culture, wellness, and brand building.

RTHMS is currently in pre-launch. The app will be available for download on the Apple App Store on February 14, when users can join a limited waitlist for the RTHMS Beta. Beta access will roll out on a controlled basis.

About Jason Winkler

Jason Winkler is a seasoned entrepreneur with a proven track record of building and scaling culture-driven brands alongside global celebrities and influential partners. He began his career as one of the youngest concert promoters in Orange County, producing and owning major live events across Orange County and Los Angeles with A-list artists. 

At 22, Jason helped launch Liquipel as an early founding partner, securing equity partnerships with Pharrell Williams and Steve Aoki and contributing to the company’s expansion into tens of thousands of retail locations nationwide. He has also consulted through his marketing agency for category-defining brands including Uber and Honest Tea, helping them establish regional market presence through culture-led marketing and experiential activations. Beyond business, Jason is actively involved in philanthropy, supporting organizations such as ICAC (Internet Crimes Against Children), Elephant Cooperation, and the Aoki Foundation, with a focus on child protection, wildlife conservation, and brain health research.

About RTHMS

RTHMS is a behavioral compatibility operating system built on real lifestyle patterns. By translating real-world behavior into dynamic Habit Tags, RTHMS forms a new foundation for connection, starting with dating and expanding into a broader system for compatibility across relationships, communities, products and everyday experiences. To learn more, visit www.rthmsapp.com.

Media Contact

Fred Dominguez
fred@wn-agency.com

A newly published scientific paper titled “Gene Expression Patterns in Lung Adenocarcinoma Cells in Response to Changes in Deuterium Concentration” (Csonka, G.I.; Papp, A.; Somlyai, I.; Somlyai, G. Int. J. Mol. Sci. 2025, 26, 10969) has validated a groundbreaking mechanism that has been central to HYD LLC for Cancer Research and Drug Development’s work for more than three decades: the concentration of deuterium — a naturally occurring hydrogen isotope — directly influences gene expression profiles that are central to cell division and cancer development.

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division. This was supported by lab experiments showing that lowering deuterium levels slowed cell growth, while increasing it accelerated it.

A new study analyzing 87 genes confirms that gene activity is sensitive to the amount of deuterium in cells. Some genes were less active in DDW, whereas most were more active in deuterated water (DEW). This supports the earlier idea that a higher D/H ratio is essential to start cell division.

The findings confirm that varying deuterium levels modulate the expression of key oncogenes and tumor-suppressor genes in human lung adenocarcinoma cells. Notably, reduced deuterium levels (as low as 40 ppm) suppressed genes associated with proliferation and drug resistance (e.g., MYCN, ETS2, ABCB1), while high deuterium environments (300 ppm) upregulated multiple oncogenic and survival pathways (EGFR, CTNNB1, STAT3, CD44).

The study confirmed that deuterium affects the same signal pathways targeted by cancer drug development, and that consuming DDW can prevent the D/H ratio from rising to a threshold level.   

“This study provides the first large-scale gene expression data linking deuterium concentration with cellular regulation in cancer,” said Dr. Gábor Somlyai, lead scientist at HYD. “It validates our long-held hypothesis that deuterium depletion can exert anticancer effects at the sub-molecular level.”

These findings help explain earlier results, in which data from 2,649 cancer patients who consumed DDW showed that adding DDW to standard treatments could reduce cancer mortality rates by up to 80% (Somlyai, G.; Papp, A.; Somlyai, I.; Kovács, B.Z.; Debrődi, M. “Real-World Data Confirm That the Integration of Deuterium Depletion into Conventional Cancer Therapy Multiplies the Survival Probability of Patients,” Biomedicines 2025, 13, 876). The new results indicate that DDW can block the activity of hundreds of genes simultaneously, which may help explain its pronounced effects.

Earlier animal studies also demonstrated that DDW could inhibit cancer-related gene expression in mice exposed to carcinogenic chemicals (Kovács, B.Z.; Puskás, L.G.; Nagy, L.I.; Papp, A.; Gyöngyi, Z.; Fórizs, I.; Czuppon, G.; Somlyai, I.; Somlyai, G. “Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients,” Cancer Control. 2022; 29:10732748211068963).

The study further supports that DDW and targeted cancer therapies may mutually enhance each other’s antitumor effects.

“This is not just about water,” Dr. Somlyai emphasized. “It’s about a paradigm shift in how we understand and manipulate the cellular environment on the sub-molecular level to fight cancer more effectively.”

Scientific Validation of a Pioneering Approach

HYD LLC for Cancer Research and Drug Development, founded in 1993, has been a global pioneer in researching deuterium depletion as a complementary cancer therapy. Their proprietary deuterium-depleted water (DDW) products are already commercially available and widely used as supportive interventions. This new study, however, offers strong mechanistic insight into how deuterium modulation works: by influencing the transcriptional activity of genes that regulate cell growth, repair, apoptosis, and survival.

The recent paper outlines a dose-dependent response, with implications for personalized and targeted cancer treatment strategies. It emphasizes the biological activity of deuterium levels as an epigenetic-like regulator, capable of reprogramming gene expression in tumor cells.

Implications for Drug Development and Oncology

This discovery opens new horizons in oncology and pharmaceutical development:

• Deuterium modulation emerges as a novel therapeutic target—not merely a passive change in water composition, but a dynamic regulator of intracellular signaling.
• Existing cancer therapies might be enhanced by combining them with deuterium-depleted environments to improve efficacy and reduce resistance.
• The study’s comprehensive gene expression data support the integration of deuterium concentration control into future cancer treatment protocols.

Next Steps for HYD

While this breakthrough represents a pivotal moment, HYD is preparing for the next stage: translating in vitro and in vivo models into clinical studies. Their 30 years of foundational research now provide a robust platform for launching a new generation of anticancer treatments based on isotopic modulation. HYD is actively seeking investment partners and pharmaceutical collaborators to conduct Phase II/III clinical trials and complete drug registration.

HYD has announced that registration is now open for the 5th International Congress on Deuterium Depletion (ICDD2026) in Budapest, Hungary, between 22 and 23 April 2026.

Registration, abstract submission, and accommodation booking at the Congress venue can be completed via the online portal.

Media Contact

Gábor Somlyai, PhD
info@hyd.hu

The preliminary review round of the 20th Hardware Innovation Design Awards recently concluded at the China Yongkang Science and Innovation Hub in Hangzhou. The prestigious competition attracted a record 3,604 submissions from 30 countries and regions worldwide, spanning both product and conceptual design categories.

A judging panel composed of industry representatives and academic experts rigorously evaluated entries based on their innovation, practicality, and potential for industrialization. Judges noted a significant increase in the readiness of industrial design entries for production, with many quickly progressing to small-batch trial manufacturing. A key trend highlighted was the integration of AI technology, which has evolved from a design aid to a core component of product innovation itself.

Corporate partners serving as co-organizers emphasized the Awards' role in driving substantive innovation in product function and structure. They pointed to emerging focal areas such as the silver economy and city companion gifts as avenues to empower the globalization of the "Yongkang Hardware" brand.

Following the review, 564 entries advanced to the next stage. The final judging round is scheduled for April. Officials from the Yongkang Science and Technology Bureau stated that the Awards will continue to act as a crucial platform for attracting global innovative resources, propelling the hardware industry toward the higher end of the global value chain.

About Hardware Innovation Design Awards

Formerly known as the China Hardware Product International Industrial Design Competition, the Hardware Innovation Design Awards were established in 2006. Over its 20 year history, the competition has attracted over 40,000 entries from more than 30 countries and regions, with the commercialized value of its design achievements exceeding 30 billion RMB. Guided by the mission of "Design Driving the Future of Hardware," the Awards are dedicated to advancing industrial transformation and upgrading, striving to be a global engine for innovation within the hardware industry. Learn more at www.ykwjdesign.com.

Sekai, an AI-native social platform, announces the public launch of its mini-app creation agent, which allows users to build interactive mini-applications through regular prompts.

The platform has scaled to 50,000 daily app creations since launching its no-code mini-app builder on Nov. 20, 2025. In under two months, Sekai users have created more than 1 million apps with the company projecting 2 million apps within three months of the update.

"At the speed we’re currently at, we could match the number of apps on the whole App Store within three months," says Lucky Zhang, founder of Sekai. “That's how fast the world is changing."

Sekai positions itself as a social platform that treats software as the backbone for shareable content with no traditional utility. Users simply describe an idea in plain text, and Sekai’s app maker creates it in seconds. The company deliberately constrains creations to brief, half-minute to one-minute experiences designed for viral distribution instead of full software applications.

Regular use cases on the platform include personalized holiday greeting cards, countdown timers that reveal gift codes, meme generators, and casual mini-games. Users can remix others’ mini-apps with customized controls, similar to how DJs sample and modify tracks. The platform's feed also displays an infinite scroll of interactive posts, surfacing high-performing AI-generated apps while filtering out broken creations.

The platform was developed by a team with deep experience in social products. Zhang previously built a variety of consumer platforms — including a short video app acquired by ByteDance and a music streaming service with 40 million users in Southeast Asia — while the company's head of recommendation spent nine years at TikTok as an early technical lead on its recommendation engine.

The company has built a cumulative user base of 2 million since 2024, initially attracting anime fans and gamers through word-of-mouth before pivoting to mainstream social sharing. Sekai now reaches approximately 50% of the daily creation volume of Lovable, a market leader in the app-building space.

“Our goal is to create the new dominant consumer platform,” Zhang explains, “Something on the scale of TikTok today. We’re building in a path not many people are leveraging.”

About Sekai

Sekai is a social media platform for personal software, where users with no coding knowledge can create interactive mini-apps and share them with others. Founded by Lucky Zhang, a veteran of consumer platforms across different industries, Sekai’s AI app creation platform leverages one of the most advanced LLM models to make app creation accessible. The company operates with a team of over 20 people and maintains a small office in San Francisco. Learn more at sekaiapp.com.

Media Contact

Aaron Zhao
aaron@sekaiapp.com

Tennessee Fertility Institute (TFI), a premier provider of best-in-class fertility services, congratulates Jane Ruman, MD, on being named a 2026 Castle Connolly Top Doctor. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Dr. Ruman earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

A board-certified Reproductive Endocrinologist & Infertility Specialist (REI), Dr. Ruman brings over 20 years of experience in reproductive medicine to her patients. As a fertility doctor and OB/GYN, Dr. Ruman’s expertise spans the entire continuum of reproductive health, from trying to conceive to fertility treatment.

"The hope and determination of my patients empowers me every day to provide the highest level of fertility care they need to build their families,” says Dr. Ruman. “I am grateful to Castle Connolly and my colleagues for this recognition.”

TFI is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Tennessee Fertility Institute

Tennessee Fertility Institute (TFI) specializes in the treatment of male and female infertility, as well as LGBTQ+ and single parent fertility. The clinic offers comprehensive fertility assessment and testing services, and its full range of comprehensive fertility services include in vitro fertilization (IVF, intrauterine insemination (IUI), fertility preservation (including egg freezing, sperm freezing, and oncofertility), third-party reproduction and more. For more information, visit www.tnfertility.com. 

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com. 

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Aspire Fertility San Antonio, a leading provider of comprehensive and best-in-class fertility services, congratulates two of its physicians, Jennifer Knudtson, MD and Aimee Browne, MD on being named 2026 Castle Connolly Top Doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.

Each Aspire Fertility San Antonio specialist is a board-certified Reproductive Endocrinologist & Infertility Specialist (REI) dedicated to providing parents with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine.

“Each day, I’m motivated by the chance to guide couples as they pursue their dreams of becoming parents, and using my training to support patients through one of life’s most difficult journeys is a true privilege,” says Dr. Browne. “I am thankful to Castle Connolly for this recognition.”

Dr. Knudtson shares, “At the heart of my approach is education and empowering patients to understand all of their reproductive healthcare options. I am honored to be recognized for my commitment to patient education and care by Castle Connolly.”

Aspire Fertility San Antonio is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. The clinic is dedicated to simplifying the fertility treatment process, streamlining communications, and offering the most advanced therapies in reproductive medicine. Its service line offerings include comprehensive diagnostic and treatments for female and male infertility, including intrauterine insemination (IUI), in vitro fertilization (IVF), egg freezing, donor services, third party reproductive services, and more. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Aspire Fertility San Antonio

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, Aspire Fertility has been helping individuals and couples build their families for 30 years. With locations in Austin, Dallas, Houston, McAllen, and San Antonio metropolitan areas, the Aspire family of clinics provides five-star fertility care to patients, led by industry experts who are on the leading edge of reproductive medicine. They offer a full spectrum of comprehensive female and male fertility care, including IVF, egg freezing, genetic screening (PGD/PGS), egg donation, surrogacy and LGBTQ+ fertility. For more information, visit www.aspirefertility.com/san-antonio-texas.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

The Reproductive Medicine Group (RMG), a premier provider of best-in-class fertility services, congratulates four doctors on being named 2026 Castle Connolly Top Doctors.  

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with RMG who were named as Top Docs include Betsy McCormick, MD; Samuel Tarantino, Jr., MD; Sandy Goodman, MD; and Timothy Yeko, MD. These physicians earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

As board-certified Reproductive Endocrinologists & Infertility Specialists (REI), each of RMG’s physicians are dedicated to providing patients with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

“On behalf of my colleagues, we want to express our gratitude to our peers for nominating us for this incredible distinction and to Castle Connolly for recognizing the work we do on behalf of our patients,” says Dr. Goodman. “It is an honor to serve our patients and provide them with the highest level of reproductive care.”

RMG is part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, and has been providing leading edge reproductive healthcare services to aspiring parents for 40 years. The clinic is guided by the highest ethical standards, providing patients with the best quality, individualized, compassionate fertility clinic care. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About The Reproductive Medicine Group

The Reproductive Medicine Group is a patient-focused fertility clinic in the Greater Tampa Bay area, with five fertility clinics in North Tampa, South Tampa, Brandon, Clearwater, and Wesley Chapel, Florida. The clinic’s fertility specialists comprise the largest team of reproductive endocrinologists in the Tampa Bay area. For more information, visit www.floridafertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Reproductive Biology Associates (RBA), a premier provider of best-in-class fertility services, congratulates four doctors on being named 2026 Castle Connolly Top Doctors.  

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with RBA who were named as Top Docs include Andrew Toledo, MD; Daniel Shapiro, MD; Jessica Rubin, MD; Michael Witt, MD; and Monica Best, MD. These physicians earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

As board-certified Reproductive Endocrinologists and Infertility Specialists (REI), each of RBA’s physicians are dedicated to providing patients with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic specialists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

“We are proud of RBA’s continued leadership in reproductive medicine and dedication to patient care,” says Dr. Andrew Toledo. “Thank you to Castle Connolly for recognizing our team as Top Doctors once again.”

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, RBA is considered one of Atlanta's top medical practices and a cornerstone in fertility treatment since 1983. The practice has contributed to over 35,000 journeys to parenthood and has led the way in groundbreaking achievements. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Reproductive Biology Associates

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, Reproductive Biology Associates (RBA) is the oldest continuously operating full-service private fertility treatment center in the United States. Since its establishment in 1983, the center’s mission has focused on the development, improvement, and application of clinical and applied sciences to improve fertility care, with its RBA team being responsible for several notable firsts in reproductive medicine. For more information, visit www.rbafertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services – and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

The Prelude Network® (Prelude), the largest and fastest-growing network of fertility centers in North America, today celebrates 48 of its physicians across 15 clinics within its expansive network who are named a 2026 Castle Connolly Top Doctor.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

Part of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, Prelude’s clinics span throughout California, Texas, New York, Indiana, Illinois, Pennsylvania, Georgia, New Jersey, Florida, Tennessee, and Western Canada. Prelude specialists include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT). 

Dr. Jamie Grifo, Program Director at NYU Langone Fertility Center and Chief Executive Physician of Inception, was named a 2026 Castle Connolly Top Doctor for the 27th year in a row. Dr. Grifo shares, “I’d like to personally congratulate my colleagues across the entire Prelude Network for being recognized for their commitment to reproductive medicine and patient care,” says Dr. Grifo. “As reproductive specialists, we understand that patients look to us for compassionate and science-based guidance that will result in the best pregnancy outcomes and it is within that responsibility that we continue to move this field of medicine forward.”

Each clinic within Prelude is dedicated to patient experience and providing compassionate, personalized fertility care through a full range of comprehensive diagnostic and treatment services, including in vitro fertilization (IVF) and intrauterine insemination (IUI), LGBTQ+ family building, third party reproductive services, fertility preservation, genetic testing, and more. 

“Our physicians exemplify the highest standards of care and leadership in reproductive medicine,” says TJ Farnsworth, founder and CEO of Inception Fertility. “We congratulate them on this achievement and thank them for the meaningful impact they make for patients every day.”

Those Prelude clinics who are included in the 2026 Top Doctor by Castle Connolly are Advanced Fertility Center of Chicago (Chicago, Illinois), Aspire Fertility Austin (Austin, Texas), Aspire Fertility Dallas (Dallas, Texas), Aspire Houston Fertility Institute (Houston, Texas), Aspire Fertility San Antonio (San Antonio, Texas), Center for Reproductive Medicine (Orlando, Florida), Indiana Fertility Institute (Carmel, Indiana), IVFMD (Miami, FL), Main Line Fertility (Philadelphia, PA), NYU Langone Fertility Center (New York, New York), NYU Langone Reproductive Specialists of New York (New York, New York), Pacific Fertility Center (San Francisco, California), Reproductive Biology Associates (Atlanta, Georgia), Reproductive Medicine Group (Tampa, Florida), Tennessee Fertility Institute (Nashville, Tennessee).

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Pacific Fertility Center (PFC), a premier provider of best-in-class fertility services, congratulates three of its doctors on being named 2026 Castle Connolly Top Doctors. 

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with PFC who were named as Top Doctors include Isabelle Ryan, MD; Jennifer Agard, MD; and Liyun Li, MD. These physicians earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

Each of PFC’s physicians is a board-certified Reproductive Endocrinologist and Infertility Specialist (REI), dedicated to delivering compassionate, individualized fertility care grounded in the latest advances in reproductive science and technology. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic physicians spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

“At PFC, our focus is on combining innovation in reproductive medicine with truly individualized care for each patient and family,” says Dr. Ryan. “We’re thankful to our colleagues for this nomination and proud to be recognized by Castle Connolly as Top Doctors.”

PFC is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. As a leading fertility treatment center known for cutting edge technology, PFC clinicians provide some of the best IVF treatment options alongside other reproductive services. Their extensive clinical experience, outstanding academic credentials, and research contributions have led to success in treating even the most challenging infertility cases. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Pacific Fertility Center

Since 1999, Pacific Fertility Center (PFC) has provided unparalleled fertility care for patients in Northern California and around the world. Each of our convenient locations features essential services, such as in vitro fertilization (IVF), fertility preservation, like egg freezing, genetic testing, and diagnosis and treatment of reproductive health concerns. Our award-winning team of fertility specialists will help you to achieve your parenthood goals. The Pacific Fertility Egg Bank program is home to one of the largest, full-service donor egg programs in Northern California. It offers clients from around the world high IVF success rates, greater convenience and lower cost than other egg donor agencies. For more information, visit www.pacificfertilitycenter.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

The Center for Reproductive Medicine (CRM), a premier provider of comprehensive and best-in-class fertility services, is excited to announce that five of its physicians have been named 2026 Castle Connolly Top Doctors.  

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with CRM named as Top Doctors include Albert Asante, MD; Jessica Feranec, MD; Randall Loy, MD; Seif Sadek, MD; and Sharon Jaffe, MD. These physicians earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the  Castle Connolly Medical Advisory Board.  

Each CRM doctor is a board-certified Reproductive Endocrinologist and Infertility Specialist (REI) dedicated to providing patients with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine. 

“Being an infertility specialist means having the opportunity to help people realize their dreams of building a family,” said Dr. Randall Loy. “My colleagues and I are honored to provide thoughtful, individualized care, and we thank Castle Connolly for this honor.”

The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Center for Reproductive Medicine

The Center for Reproductive Medicine is committed to helping our patients achieve their dreams of parenthood by offering uncompromising clinical excellence and truly compassionate care. Since 1985, our providers have helped thousands of central Florida patients build their families. Combining decades of experience with state-of-the-art technology, we are known for providing individualized treatment plans and the most cost-efficient options to give our patients every chance of conception. For more information, visit www.ivforlando.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility.  Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others.  Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida).  For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes.  Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership.   Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.  For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Main Line Fertility, a premier provider of best-in-class fertility services, congratulates five doctors on being named 2026 Castle Connolly Top Doctors. 

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with Main Line Fertility who were named Top Doctors include Allison Bloom, DO; Benjamin Gocial, MD; Michael J. Glassner, MD, and Shahab S. Minassian, MD. These physicians earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

Each of Main Line Fertility’s physicians is a board-certified Reproductive Endocrinologist and Infertility Specialist (REI), dedicated to delivering compassionate, individualized fertility care grounded in the latest advances in reproductive science and technology. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

"I am so proud of the team at Main Line Fertility, who have dedicated their careers to helping build families through compassionate and personalized care,” says Dr. Glassner. “We thank Castle Connolly for this recognition.”

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT). 

About Main Line Fertility

Main Line Fertility has emerged as the leading fertility center in the greater Philadelphia area. They strive to help individuals and couples achieve their family-building goals, combining cutting-edge technologies with personalized care. At each of our six fertility clinics, you’ll find verifiable success rates, a wide array of customized treatment plans, and financial programs. They offer comprehensive reproductive health services, including intrauterine insemination (IUI), in vitro fertilization (IVF), fertility assessments, and more. For more information, visit www.mainlinefertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas) ; Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services – and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

IVFMD, a premier provider of best-in-class fertility services, congratulates 4 doctors on being named 2026 Castle Connolly Top Doctors. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with IVFMD who were named Top Docs include Connie E. Alford Bartruff, MD; Jenifer McCarthy, MD, Kenneth M.Gelman, MD, and Sabrina A. Gerkowicz, MD. These physicians earned this recognition from a pool of over one million U.S. doctors.

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board. 

Each of IVFMD’s physicians is a board-certified Reproductive Endocrinologist and Infertility Specialist (REI), dedicated to delivering compassionate, individualized fertility care grounded in the latest advances in reproductive science and technology. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors.

"We are truly honored that Castle Connolly has recognized our service and dedication to patients and the field of reproductive medicine,” says Dr. McCarthy. “We thank Castle Connolly for this distinguished honor.”

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About IVFMD

Founded in 1991, IVFMD has helped over 10,000 couples from all over the world achieve their dreams of having a baby through compassionate and personalized care rooted in groundbreaking methodologies and state-of-the-art facilities with the industry’s most advanced technology. IVFMD has locations in Miami, Cooper City, Boca-Raton, Jupiter, Viera and Naples, Florida. For more information, visit www.ivfmd.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility(Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Indiana Fertility Institute (IFI), a premier provider of comprehensive and best-in-class fertility services, is excited to announce that two of its physicians have been named 2026 Castle Connolly Top Doctors.  

Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Those with IFI named as Top Doctors include John Jarrett, II, MD and Meredith Provost, MD. These physicians earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.  

Each IFI doctor is a board-certified Reproductive Endocrinologist and Infertility Specialist dedicated to providing parents with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine.  

“I am honored to be recognized by my peers and Castle Connolly for my commitment to patient care,” says Dr. Provost. “To help patients become parents is very rewarding, and I am thankful for the opportunity to do this work.” 

“Being an REI has allowed me to walk alongside patients during some of their most challenging times, and that’s why our approach to personalized care is so important,” says Dr. Jarrett. “I thank my colleagues and Castle Connolly for this honor.”

The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Indiana Fertility Institute

For over 30 years, Indiana Fertility Institute (IFI) has provided patients throughout Indiana with exceptional fertility care. Specializing in male and female infertility, IFI’s fertility doctors provide a comprehensive array of services, including fertility assessments (AMH testing, semen analysis, etc.), intrauterine insemination (IUI), in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), fertility preservation (egg freezing, sperm freezing, oncofertility), preimplantation genetic testing (PGT), LGBTQ+ fertility care, third-party reproduction, sperm retrieval, and reproductive surgery. IFI also offers fertility financing options, multicycle plans, and other affordable options to help you navigate fertility care costs. For more information, visit www.fertilityindy.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility(Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Aspire Houston Fertility Institute (Aspire HFI), a premier provider of comprehensive and best-in-class fertility services, is excited to announce that three of its physicians have been named 2026 Castle Connolly Top Doctors.  

Those with Aspire HFI named as Top Doctors include Randall Dunn, MD; George Grunert, MD; and S. Kemi Nurudeen, MD. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. These physicians earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.  

Each Aspire HFI doctor is a board-certified Reproductive Endocrinologist and Infertility Specialist dedicated to providing parents with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine. 

“My colleagues and I are honored to help patients navigate their fertility options and develop personalized treatment plans to reach their family-building goals,” said Dr. Randall Dunn. “I’m proud of our team and grateful to Castle Connolly for this recognition.”

The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Aspire Houston Fertility Institute

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, Aspire Fertility has been helping individuals and couples build their families for 30 years. With locations in Austin, Dallas, Houston, McAllen, and San Antonio metropolitan areas, the Aspire family of clinics provides five-star fertility care to patients, led by industry experts who are on the leading edge of reproductive medicine. They offer a full spectrum of comprehensive female and male fertility care, including IVF, egg freezing, genetic screening (PGD/PGS), egg donation, surrogacy and LGBTQ+ fertility. For more information, visit www.aspirehfi.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility(Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Aspire Fertility Dallas, a premier provider of comprehensive and best-in-class fertility services, congratulates its Medical Director, Dr. Christine Mansfield on being named a 2026 Castle Connolly Top Doctor. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Dr. Mansfield earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.  

Dr. Mansfield, who serves as the medical director at Aspire Fertility Dallas, is board-certified in Reproductive Endocrinology and Obstetrics and Gynecology by the American Board of Obstetrics and Gynecology. She is a member of the American College of Obstetricians and Gynecologists, American Society of Reproductive Medicine, and the Society of Reproductive Endocrinology and Infertility. 

“I’m grateful to be recognized as a Castle Connolly Top Doctor and for the acknowledgment of the care I provide my patients every day,” said Dr. Mansfield. “I sincerely thank my colleagues for the nomination and Castle Connolly for this honor.”

Aspire Fertility Dallas is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. The clinic is guided by the highest ethical standards, providing patients with the best quality, individualized, compassionate fertility clinic care. Its service line offerings include comprehensive diagnostic and treatments for female and male infertility, including intrauterine insemination (IUI), in vitro fertilization (IVF), egg freezing, donor services, third party reproductive services, and more. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).   

About Aspire Fertility Austin

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, Aspire Fertility has been helping individuals and couples build their families for 30 years. With locations in the Austin, Dallas, Houston, and San Antonio metropolitan areas, the Aspire family of clinics provides five-star fertility care to patients, led by industry experts who are on the leading edge of reproductive medicine. They offer a full spectrum of comprehensive female and male fertility care, including IVF, egg freezing, genetic screening (PGD/PGS), egg donation, surrogacy and LGBTQ+ fertility. For more information, visit www.aspirefertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes.  Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception – Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

Aspire Fertility Austin, a premier provider of best-in-class fertility services, congratulates Dr. Deborah Ikhena-Abel and Dr. Angela Kelley on being named 2026 Castle Connolly Top Doctors. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. These physicians earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.  

As board-certified Reproductive Endocrinologist and Infertility Specialists (REIs), Aspire Fertility Austin’s physicians are dedicated to providing patients with compassionate and individualized fertility care that is rooted in the latest science and technologies in reproductive medicine. The clinic is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

“We’re grateful to our peers for this nomination and to Castle Connolly for recognizing our work,” said Dr. Kelley. “It’s an honor to serve our patients and provide the highest quality reproductive care.”

Dr. Ikhena-Abel continued, “It’s a privilege to use our expertise to help our patients overcome their fertility challenges and educate them on their fertility options. We thank Castle Connolly for recognizing what we do on behalf of our patients.” 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Aspire Fertility Austin

Part of The Prelude Network (Prelude), the largest network of fertility clinics in North America, Aspire Fertility has been helping individuals and couples build their families for 30 years. With locations in the Austin, Dallas, Houston, and San Antonio metropolitan areas, the Aspire family of clinics provides five-star fertility care to patients, led by industry experts who are on the leading edge of reproductive medicine. They offer a full spectrum of comprehensive female and male fertility care, including IVF, egg freezing, genetic screening (PGD/PGS), egg donation, surrogacy and LGBTQ+ fertility. For more information, visit www.aspirefertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida).  For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes.  Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.   For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com

The Advanced Fertility Center of Chicago (AFCC), a premier provider of best-in-class fertility services, congratulates Michelle Catenacci, MD on being named a 2026 Castle Connolly Top Doctor. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. Dr. Catenacci earned this recognition from a pool of over one million U.S. doctors. 

Castle Connolly Top Doctors are nominated by their peers, after which the Castle Connolly research team evaluates specific criteria to determine who should qualify as a Top Doctor, including consideration of each nominee’s professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, disciplinary history, interpersonal skills, and outcomes data. The recognition methodology has been vetted and endorsed by the Castle Connolly Medical Advisory Board.  

A board-certified Reproductive Endocrinologist and Infertility Specialist (REI), Dr. Catenacci has dedicated her career to helping aspiring parents build their families through compassionate and personalized care. Her specialties include the diagnosis and treatment of fibroids, uterine septums, and uterine adhesions.

“It’s a privilege to partner with patients each day as they face fertility challenges and pursue their dreams of building a family,” says Dr. Catenacci. “I am thankful to Castle Connolly for recognizing my efforts to deliver quality reproductive services and care to my patients.”

AFCC is part of The Prelude Network® (Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. In total, 48 physicians across Prelude were named 2026 Castle Connolly Top Doctors. 

Prelude is the clinical network of Inception Fertility™ (Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today’s most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT).

About Advanced Fertility Center of Chicago

Advanced Fertility Center of Chicago (AFCC) is committed to providing patients throughout Illinois and beyond with the best fertility clinic and IVF experience. Pioneers in the field, our infertility and reproductive specialists consistently beat the national average with high IVF success rates. We offer a wide range of services for problems conceiving, recurrent miscarriage, 40-plus fertility treatment, LGBTQ+ fertility, male fertility, and more. Our services include AMH testing, in vitro fertilization (IVF), intrauterine insemination (IUI), PGT genetic testing, frozen embryo transfer, fertility preservation (egg freezing, oncofertility), egg donation, gestational surrogacy, and reproductive surgery. For more information, visit advancedfertility.com.

About The Prelude Network

The Prelude Network (Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility — a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility.  Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on excellence in science, medicine and the patient experience.  The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Houston Fertility Institute (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). For more information, visit www.preludefertility.com.

About Inception Fertility

Inception Fertility™ (Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Our doctors are some of the first to use breakthrough assisted reproductive technologies (ART) — including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services — and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations — which includes The Prelude Network®, the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank®, one of the largest frozen donor egg banks in North America; BUNDL Fertility™, a multi-cycle fertility service bundling program; HavenCryo™, a long-term reproductive preservation and storage solution provider and NutraBloom®, a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception — Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations.  For more information, visit www.inceptionfertility.com.

Media Contact

Mia Humphreys
MHumphreys@kruppagency.com
+1 239-297-6592

Brosix, a team messaging and internal communication platform used by small and mid-sized teams worldwide, has shared an overview of its product progress during 2025 and outlined its priorities for 2026.

During 2025, Brosix focused on reinforcing the stability and reliability of its platform while continuing to improve the everyday experience for teams that rely on it for internal communication. The year included infrastructure upgrades, improvements to desktop applications, expanded administrative controls, and a series of practical updates aimed at making team communication smoother and easier to manage.

“As Brosix marks twenty years in team messaging, our focus remains the same as it was at the beginning — keeping communication simple and dependable,” said Stefan Chekanov, co-founder of Brosix. “Our goal is to give companies a messaging platform that is easy to use from day one, without requiring training or complex configuration, while still meeting the practical needs of managing a team.”

Looking ahead to 2026, Brosix plans to continue investing in reliability, performance, and clarity across all supported platforms. Rather than introducing disruptive changes, the company’s roadmap emphasizes steady, well-tested improvements that help teams communicate effectively without disrupting established workflows.

Brosix is designed for organizations that want a focused communication tool without the noise or complexity often associated with larger collaboration platforms. The platform supports one-on-one and group messaging, file sharing, audio and video calls, screen sharing, and chat rooms, all within a private, well-managed communication environment.

A detailed overview of Brosix’s work in 2025 and its plans for 2026 is available on the company blog.

About Brosix

Brosix is a team communication and internal messaging platform built for companies that value stability, ease of use, and long-term reliability. It helps teams chat, share files, and communicate in real time through a private, secure and easy-to-manage platform that works out of the box, without complex setup or dedicated IT resources. Founded 20 years ago, Brosix is used by teams across different industries to keep internal communication simple, focused, and dependable. For more information, visit www.brosix.com.

Media Contact

Stefan Chekanov
pr@brosix.com

Warp today announced the launch of Oz, a cloud-based platform for running, managing, and orchestrating coding agents at scale. With Oz, visibility, auditability, and developer control are built in, so organizations can deploy hundreds of coding agents in parallel without spending time and effort building custom infrastructure.

As teams increase their use of coding agents, they quickly run into practical limits. According to Industry research, while most organizations have adopted AI coding tools, fewer than one in ten have deployed agents in production. With 90% of enterprise software engineers predicted to use AI code assistants by 2028, the gap isn't adoption intent. It's the infrastructure to deploy agents across your organization with the governance, visibility, and automation required, especially for large and enterprise teams.

“Today, most agents run on individual laptops with no centralized visibility or audit trail,” said Zach Lloyd, founder and CEO at Warp. “Oz moves agents into the cloud so companies can run hundreds of agents safely and with full oversight. It’s the difference between giving engineers a faster bicycle and giving the organization a transportation system.”

With Oz, teams can:

• Run hundreds of parallel cloud agents to multithread complex development tasks
• Automate repetitive workflows such as feature-flag cleanup, documentation updates, security checks, or incident response
• Build applications on top of agents, including bug triage and incident response systems

Oz moves agents into secure, sandboxed cloud environments powered by Docker where agents can make multi-repo changes and leverage shared team context. Every agent run generates a shareable link and audit trail, which can be accessed via CLI or API by any team member behind access control. Environments can be hosted on Warp’s infrastructure or can be self-hosted for enterprise customers with custom security and networking requirements.

Developers using Oz can launch agents interactively or programmatically, run hundreds of agents in parallel, and schedule recurring workflows, without building their own infrastructure for sandboxing or tracking. While Oz is deeply integrated into Warp’s flagship product, Warp Terminal, it is usable as a standalone agent orchestration product wherever developers choose to build software.

Get started today by downloading Warp, visiting www.warp.dev/oz, or installing the Oz CLI.

About Warp

Warp is the platform for agentic development. What began as a reimagined terminal has evolved into an Agentic Development Environment where engineers orchestrate AI agents to build, deploy, and debug production software. Today, Warp is used by over 700,000 developers at companies including Docker, Ramp, and Peloton, as well as leading AI labs, Big Tech companies, and over half of the Fortune 500. The company was founded by Zach Lloyd, former engineering lead for Google Sheets and the Google Docs suite, and is backed by Sequoia Capital, GV, Sam Altman, Marc Benioff, and Dylan Field. Warp is based in New York and can be found online at www.warp.dev.

Media Contact

Kathleen Eagan
press@warp.dev